This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Anastrozole

Read time: 1 mins
Marketing start date: 18 Nov 2024

Summary of product characteristics


Effective Time

20220803

Version

8

Spl Product Data Elements

Anastrozole Anastrozole ANASTROZOLE ANASTROZOLE HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM STARCH GLYCOLATE TYPE A POTATO POVIDONE TITANIUM DIOXIDE POLYETHYLENE GLYCOL, UNSPECIFIED WHITE ROUND A7

Application Number

ANDA078921

Brand Name

Anastrozole

Generic Name

Anastrozole

Product Ndc

65841-743

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Anastrozole Tablets, 1 mg NDC 65841-743-10 1,000 tablets Rx only Anastrozole Tablets, 1mg

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.